Daiichi Sankyo Company, Limited (4568.T)
JPY 4342.0
(-0.02%)
JPY 4342.0
(-0.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 305.45 Billion JPY | 23.19% |
| 2022 | 169.71 Billion JPY | 47.71% |
| 2021 | 143.04 Billion JPY | 2.42% |
| 2020 | 121.17 Billion JPY | -33.4% |
| 2019 | 191.41 Billion JPY | 46.17% |
| 2018 | 129.87 Billion JPY | 4.54% |
| 2017 | 122.96 Billion JPY | -7.66% |
| 2016 | 136.3 Billion JPY | -20.5% |
| 2015 | 174.71 Billion JPY | 43.64% |
| 2014 | 116.44 Billion JPY | -29.78% |
| 2013 | 163.41 Billion JPY | 19.55% |
| 2012 | 148.37 Billion JPY | -53.9% |
| 2011 | 95 Billion JPY | -1.95% |
| 2010 | 179.03 Billion JPY | 9.79% |
| 2009 | 157.91 Billion JPY | -52.78% |
| 2008 | 109.22 Billion JPY | 218.93% |
| 2007 | 205.71 Billion JPY | -20.58% |
| 2006 | 170.74 Billion JPY | 23.58% |
| 2005 | 178.33 Billion JPY | 78.04% |
| 2004 | 106.84 Billion JPY | -7.75% |
| 2003 | 123.7 Billion JPY | 17.04% |
| 2002 | 105.69 Billion JPY | 31.05% |
| 2001 | 80.65 Billion JPY | -8.13% |
| 2000 | 87.79 Billion JPY | -38.48% |
| 1999 | 142.71 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 109.23 Billion JPY | 0.92% |
| 2024 Q1 | 109.59 Billion JPY | 231.6% |
| 2023 Q4 | 32.81 Billion JPY | -73.58% |
| 2023 FY | - JPY | 23.19% |
| 2023 Q1 | 67.02 Billion JPY | 222.58% |
| 2023 Q2 | 70.28 Billion JPY | 4.86% |
| 2023 Q3 | 124.22 Billion JPY | 76.74% |
| 2022 FY | - JPY | 47.71% |
| 2022 Q3 | 54.52 Billion JPY | -31.56% |
| 2022 Q1 | 50.79 Billion JPY | 247.63% |
| 2022 Q2 | 79.67 Billion JPY | 56.86% |
| 2022 Q4 | 20.77 Billion JPY | -61.89% |
| 2021 Q3 | 55.51 Billion JPY | 3.01% |
| 2021 Q4 | -34.4 Billion JPY | -161.97% |
| 2021 FY | - JPY | 2.42% |
| 2021 Q1 | 62.5 Billion JPY | 707.85% |
| 2021 Q2 | 53.89 Billion JPY | -13.77% |
| 2020 Q1 | 56.29 Billion JPY | 3471.02% |
| 2020 FY | - JPY | -33.4% |
| 2020 Q2 | 40.62 Billion JPY | -27.83% |
| 2020 Q3 | 47.69 Billion JPY | 17.39% |
| 2020 Q4 | -10.28 Billion JPY | -121.56% |
| 2019 Q1 | 73.94 Billion JPY | 60509.02% |
| 2019 FY | - JPY | 46.17% |
| 2019 Q4 | -1.67 Billion JPY | -101.93% |
| 2019 Q3 | 86.58 Billion JPY | 94.41% |
| 2019 Q2 | 44.53 Billion JPY | -39.77% |
| 2018 FY | - JPY | 4.54% |
| 2018 Q2 | 41.46 Billion JPY | -4.53% |
| 2018 Q1 | 43.43 Billion JPY | 1973.9% |
| 2018 Q4 | 122 Million JPY | -99.77% |
| 2018 Q3 | 53.57 Billion JPY | 29.2% |
| 2017 Q3 | 59.19 Billion JPY | 181.67% |
| 2017 Q2 | 21.01 Billion JPY | -61.29% |
| 2017 Q1 | 54.28 Billion JPY | 310.7% |
| 2017 Q4 | -2.31 Billion JPY | -103.92% |
| 2017 FY | - JPY | -7.66% |
| 2016 Q2 | 37.89 Billion JPY | -36.67% |
| 2016 Q4 | -25.76 Billion JPY | -135.02% |
| 2016 Q1 | 59.83 Billion JPY | 875.63% |
| 2016 FY | - JPY | -20.5% |
| 2016 Q3 | 73.57 Billion JPY | 94.17% |
| 2015 FY | - JPY | 43.64% |
| 2015 Q4 | -7.71 Billion JPY | -111.56% |
| 2015 Q1 | 61.14 Billion JPY | 247.5% |
| 2015 Q2 | 59.55 Billion JPY | -2.59% |
| 2015 Q3 | 66.73 Billion JPY | 12.04% |
| 2014 Q2 | 57.92 Billion JPY | 23.27% |
| 2014 FY | - JPY | -29.78% |
| 2014 Q4 | -41.45 Billion JPY | -166.79% |
| 2014 Q3 | 62.06 Billion JPY | 7.14% |
| 2014 Q1 | 46.99 Billion JPY | 32.51% |
| 2013 Q2 | 40.44 Billion JPY | 21.4% |
| 2013 Q3 | 51.79 Billion JPY | 28.06% |
| 2013 Q4 | 35.46 Billion JPY | -31.54% |
| 2013 FY | - JPY | 19.55% |
| 2013 Q1 | 33.31 Billion JPY | 1654.45% |
| 2012 Q2 | 17.16 Billion JPY | -52.94% |
| 2012 Q3 | 40.98 Billion JPY | 138.82% |
| 2012 Q4 | 1.89 Billion JPY | -95.37% |
| 2012 FY | - JPY | -53.9% |
| 2012 Q1 | 36.46 Billion JPY | -78.84% |
| 2011 Q2 | 94.59 Billion JPY | 101.91% |
| 2011 Q3 | -47.82 Billion JPY | -150.55% |
| 2011 Q4 | 172.3 Billion JPY | 460.31% |
| 2011 FY | - JPY | -1.95% |
| 2011 Q1 | 46.85 Billion JPY | -17.54% |
| 2010 FY | - JPY | 9.79% |
| 2010 Q3 | 84.74 Billion JPY | 10.24% |
| 2010 Q2 | 76.87 Billion JPY | -30.92% |
| 2010 Q1 | 111.28 Billion JPY | 78.8% |
| 2010 Q4 | 56.81 Billion JPY | -32.96% |
| 2009 Q1 | 70.63 Billion JPY | 46.28% |
| 2009 FY | - JPY | -52.78% |
| 2009 Q4 | 62.24 Billion JPY | -31.97% |
| 2009 Q3 | 91.48 Billion JPY | 20.43% |
| 2009 Q2 | 75.96 Billion JPY | 7.55% |
| 2008 Q2 | 54.43 Billion JPY | 0.0% |
| 2008 FY | - JPY | 218.93% |
| 2008 Q3 | 440.75 Billion JPY | 709.65% |
| 2008 Q4 | 48.28 Billion JPY | -89.05% |
| 2007 FY | - JPY | -20.58% |
| 2006 FY | - JPY | 23.58% |
| 2005 FY | - JPY | 78.04% |
| 2004 FY | - JPY | -7.75% |
| 2003 FY | - JPY | 17.04% |
| 2002 FY | - JPY | 31.05% |
| 2001 FY | - JPY | -8.13% |
| 2000 FY | - JPY | -38.48% |
| 1999 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 117.59 Billion JPY | -159.765% |
| Astellas Pharma Inc. | 195.34 Billion JPY | -56.372% |
| Chugai Pharmaceutical Co., Ltd. | 470.91 Billion JPY | 35.135% |
| Ono Pharmaceutical Co., Ltd. | 178.43 Billion JPY | -71.187% |
| Santen Pharmaceutical Co., Ltd. | 56.45 Billion JPY | -441.045% |
| JCR Pharmaceuticals Co., Ltd. | 10.72 Billion JPY | -2747.031% |
| Otsuka Holdings Co., Ltd. | 224.19 Billion JPY | -36.244% |
| Perseus Proteomics Inc. | -892 Million JPY | 34344.17% |